Skip to Main Content

2016 Neuroendocrine Tumor Patient ConferenceUCSF Diller navy
Hosted by:UCSF Helen Diller Family Comprehensive Cancer Center
In cooperation with NorCal CarciNET Community, NET Research Foundation, Stanford University Medical Center

Sunday, January 24, 2016 - 9:00 am to 4:30 pm

View the recording of the LiveStream  



Please join us for a day of discussion on the latest developments in neuroendocrine tumor (NET) research and treatment. Topics will include treatment options, clinical trials and phase III results, nuclear medicine and molecular imaging as well as strategies for living with cancer.  Experts from around the world will be giving presentations and participating in Tumor Boards and extensive Q&A.

New this year - Pre Conference Primer on NETs - For those who are newly diagnosed or need a refresher on the basics of NETs - we will have a 30 min pre-conference overview on NETs.  Please indicate your interest in this primer on your registration form.
We will also have smaller breakouts for caregivers and those that need a break from the main conference.

Open to patients, caregivers and those interested in NETs.

Thanks to generous funding by UCSF, there is no cost to attend this conference. Conference registration includes lunch and parking.
Registration ends on January 20, 2016


Agenda - Subject to Change

Click here to download the program with speaker biography.

8:00   Registration Opens 
Robertson Auditorium - 2nd Level UCSF Mission Bay Conference Center
8:30 NETS Overview 
- Pre Conference session for the newly diagnosed
8:55 Break 
9:05 Opening Remarks
Alan Ashworth, PhD, FRS
President, UCSF Helen Diller Family Comprehensive Cancer Center
  Morning Session - Moderator: Bergsland 
9:25 2015: Year in Review
(including results of 3 phase III clinical trials in NETs and ongoing trials)   
10:00 Break 
10:15 Molecular Imaging and Radiotherapeutics 
  Advances in Imaging for NETS Hope
  Peptide Receptor Radionuclide Therapy (PRRT):
NETTER-1 results and 15 years of institutional experience
  PRRT: Next Steps and Ongoing Trials  Mittra
11:05 Liver Directed Therapy for NETS Sze
11:30 Biomarkers in a Nutshell Liu
11:45 Morning Q&A All
12:15 Lunch 
1:00 The Warner Advocacy Award Salamakha
Warner Advocacy
Award Committee
  Afternoon Session - Moderator: Nakakura 
1:15 Tumor Board: Integrating therapeutic options:
Is there an optimal sequence for PanNET or Carcinoid
2:00 Assembling and Coordinating With Your Health Care Team
(e.g. local providers, NET specialists and multidisciplinary teams)


2:30 Immunotherapy 101:
Successes, limitations, and prospects for the future
3:15 Break 
3:30 Funding NET Research:
What does it take to bring a drug from the bench to the bedside? 
3:50 Living With NETS:
Optimizing coping skills for patients and their caregivers
4:30 Wrap Up Bergsland

Breakout Room
Leach Conference Room 1 - 2nd Floor, Mission Bay Conference Center
Small session for those that are intrested and need a break from the main conference

10:15- Noon Get Moving! Mini Exercise Sessions &
Ask the UCSF Exercise Counselor
Clark & Fedric (UCSF)
1:15 - 2:00 The Cancer Journey Roadmap

The Cancer Journey

2:30 - 3:15 Caring for the Care Giver Maslan
Cancer Support Community
3:30 - 4:00 What You Need to Know About High-Grade NETs Bergsland
4:00 - 4:30 What You Need to Know About Lung NETs Liu

Throught the Day - Foyer Area

  Ask the Nutritionist Macire
  Ask the Leagal Workplace Rgihts Experts  Legal Aid Society
  Chair Massage McKinnon Body Therapy


Paritial List of Faculty:

Bergland Dr. Emily Bergsland, Ernest Rosenbaum, MD, Endowed Chair in Medical Oncology, UCSF. Dr. Bergsland specializes in GI Cancer and is a member of the NCI Task force on NETs. In her research, she focuses on developing and testing new cancer therapies. She is a professor of clinical medicine at UCSF.
baum Prof. Dr. Richard P. Baum, Chief,Center for Molecular Radiotherapy / Department of Molecular Imaging (PET/CT). ZentralKlinik Bad Berka. ZentralKlinik Bad Berka is an ENETS Center of Excellence with over 1,500 NET patient visits a year.
hope Dr. Thomas Hope, Assistant Professor in Residence, UCSF School of Medicine.
pamela kunz Dr. Pamela Kunz, Assistant Professor of Medicine at the Stanford University Medical Center
iagaru Dr. Andrei IagaruDivision of Nuclear Medicine & Molecular Imaging Co-Chief, Stanford.
web DSC5344T  Josh Mailman, President, NorCal CarciNET Community. 

Dr. Eric Nakakura, M.D., Ph.D., Associate Professor of Surgery, UCSF.

Ron Ron Hollander,  Executive Director Neuroendocrine Tumor Research Foundation (NETRF).  NETRF has funded over $2 million dollars in research in the San Francisco Bay Area. 
 Shumay Dianne Shumay, PhD, Clinical Psychologist ,Associate Director of Psycho-Oncology, UCSF 

Watch the 2014 Conference below.